Literature DB >> 20034794

The contribution of human synovial stem cells to skeletal muscle regeneration.

Jinhong Meng1, Carl F Adkin, Virginia Arechavala-Gomeza, Luisa Boldrin, Francesco Muntoni, Jennifer E Morgan.   

Abstract

Stem cell therapy holds promise for treating muscle diseases. Although satellite cells regenerate skeletal muscle, they only have a local effect after intra-muscular transplantation. Alternative cell types, more easily obtainable and systemically-deliverable, were therefore sought. Human synovial stem cells (hSSCs) have been reported to regenerate muscle fibres and reconstitute the satellite cell pool. We therefore determined if these cells are able to regenerate skeletal muscle after intra-muscular injection into cryodamaged muscles of Rag2-/gamma chain-/C5-mice. We found that hSSCs possess only limited capacity to undergo myogenic differentiation in vitro or to contribute to muscle regeneration in vivo. However, this is enhanced by over-expression of human MyoD1. Interestingly, hSSCs express extracellular matrix components laminin alpha2 and collagen VI within grafted muscles. Therefore, despite their limited capacity to regenerate skeletal muscle, hSSCs could play a role in treating muscular dystrophies secondary to defects in extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20034794     DOI: 10.1016/j.nmd.2009.11.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 2.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

3.  Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes.

Authors:  Manuel A F V Gonçalves; Josephine M Janssen; Quynh G Nguyen; Takis Athanasopoulos; Stephen D Hauschka; George Dickson; Antoine A F de Vries
Journal:  Mol Ther       Date:  2011-01-25       Impact factor: 11.454

Review 4.  Duchenne muscular dystrophy: current cell therapies.

Authors:  Dorota Sienkiewicz; Wojciech Kulak; Bożena Okurowska-Zawada; Grażyna Paszko-Patej; Katarzyna Kawnik
Journal:  Ther Adv Neurol Disord       Date:  2015-07       Impact factor: 6.570

5.  Skeletal Muscle Regenerative Engineering.

Authors:  Xiaoyan Tang; Leila Daneshmandi; Guleid Awale; Lakshmi S Nair; Cato T Laurencin
Journal:  Regen Eng Transl Med       Date:  2019-04-02

6.  Isolation, characterization, and differentiation of stem cells for cartilage regeneration.

Authors:  Olivia S Beane; Eric M Darling
Journal:  Ann Biomed Eng       Date:  2012-08-21       Impact factor: 3.934

7.  Controlled delivery of SDF-1α and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery.

Authors:  Viktoriya Y Rybalko; Chantal B Pham; Pei-Ling Hsieh; David W Hammers; Melissa Merscham-Banda; Laura J Suggs; Roger P Farrar
Journal:  Biomater Sci       Date:  2015-11       Impact factor: 6.843

8.  Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.

Authors:  Jinhong Meng; Carl F Adkin; Shi-wen Xu; Francesco Muntoni; Jennifer E Morgan
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

9.  The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells.

Authors:  Jinhong Meng; Maximilien Bencze; Rowan Asfahani; Francesco Muntoni; Jennifer E Morgan
Journal:  Skelet Muscle       Date:  2015-04-28       Impact factor: 4.912

10.  Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin.

Authors:  Anete Rozkalne; Carl Adkin; Jinhong Meng; Ariya Lapan; Jennifer E Morgan; Emanuela Gussoni
Journal:  Hum Gene Ther       Date:  2013-12-19       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.